36
Amphiphilic conetwork gel membranes based on biocompatible polymers and their applications CSIR- CSMCRI CSIR-SRF (GATE) Assessment Presentation Arvind Kumar Singh Chandel Enrolment no: 10BB14J16016 Under the guidance of Reverse Osmosis (Membrane) Division CSIR- Central Salt & Marine Chemicals Research Institute Bhavnagar, Gujarat-364002 Dr. Suresh K. Jewrajka Co-supervisior Dr. Soumya Haldar

sustained release

Embed Size (px)

Citation preview

Page 1: sustained release

Amphiphilic conetwork gel membranes based on biocompatible polymers and their applications

CSIR-CSMCRI

CSIR-SRF (GATE) Assessment Presentation

Arvind Kumar Singh Chandel Enrolment no: 10BB14J16016

Under the guidance of

Reverse Osmosis (Membrane) Division CSIR- Central Salt & Marine Chemicals Research Institute

Bhavnagar, Gujarat-364002

Dr. Suresh K. JewrajkaCo-supervisior

Dr. Soumya Haldar

Page 2: sustained release

Objective The main objective of this work is the synthesis of biocompatible biodegradable amphiphilic conetwork gel membranes for biomedical applications.The objectives of the thesis work may subdivided as follows: Synthesis and functionalization biocompatible/biodegradable

(co)polymers. Chemical reaction of copolymers and cross-linker to obtain gel

membranes. Combining premade polysaccharide with functional hydrophobic

polycaprolactone-based copolymers to obtained amphiphilic gel membrane with desirable characters for drug delivery and tissue engineering applications. Synthesis and functionalization ofhydrophilic and hydrophobic polymers/copolymers

Cross-linking  Amphiphilic gel membranes

Biomedical applications

Page 3: sustained release

IntroductionGel materials Chemically or physically cross-linked soft insoluble materials those swell in solvents.

Gel

Hydrogel Amphiphilic conetwork gel

Formed by combination of purely hydrophilic polymersEg. Starch gel, agarose gel, PEG gel

Formed by combination of hydrophilic and hydrophobicpolymers and forms co-continuous morphologye.g. PEG/PCL gel PMMA/PDMA gel

Adv. Drug Delivery Rev.2002, 54, 135–147..Curr.Med.Chem. 2013;20(1):79-94.

Page 4: sustained release

HC

H2C p

Cl

HC CH2

Cl

AIBN

(B)

Polycaprolactone diolCl

ClO

OOOO

OH

O

HOn n

Et3N/ 24 hroom temperature

OOO

OO

OO

OO

Cl

OO

O

Cl

On n

(C)

ClCH2-Ph-PCL-Ph-CH2ClO O

OO OH

OOOH

O

CH2

CH3C COOCH3

HO

CH2

C CH3CO

OCH2

CH2

NMe2

O OO

O OHOO

OH

OHHO

Agr

iBuBr/Et3N

O OO

O OHOO

OH

O

COCH3C CH3

Br

HO

OOO

OHOO O

HO

O

H2CC CH3H3COOC

OH

H2CCH3C C

O

OCH2

CH2

NMe2

MMA+DMA/CuBr+bpy

(2) DMA/CuBr+bpy(1) MMA/CuBr+bpy

Agr-I

(A)

Agr-g-PMMA-b-PDMA Agr-g-PMMA-co-PDMA

Amphiphilic gel (APG) of graft copolymer of agarose (Agr) and polycaprolactone (PCL) or polychloromethyl styrene (PCMSt)

Synthesis of precursors

Scheme 1. Synthesis of precursors

Page 5: sustained release

O OO

O OHOO

OH

O

CH2

CH3C COOCH3

CH2

CH3C

HOO O

OO OH

OOH

O

CH2

CH3C COOCH3

CH2

CH3C CO

OCH2

CH2

Me2N

HOO O

OO OH

OOH

O

CH2

CH3C COOCH3

CH2

CH3C

HO

m m m

H2CC CH3C

O

OCH2CH2

Me2N

n

CH2

C CH3CO

OCH2CH2

Me2N

n

CH2

C CH3CO

OCH2CH2

Me2N

n

CO

OCH2

CH2

Me2N

CO

OCH2

CH2

Me2N

HC

HC

H2C

HC

H2C

HC

H2C

HC C

H2HC

H2C

HC

H2C

HC

H2C

HC

H2C

HC C

H2

H2C

Anotherpolymerchain

Styrenic backbone

Agr-g-PMMA-b-PDMA

70 OC

HC

H2C p

Cl

O OO

O OH OOOH

OCOCH3C CH3

CH2

CH3C COOCH3

CH2

CH3C

HOO O

OO OH O

OH

OCOCH3C CH3

CH2

CH3C COOCH3

CH2

CH3C CO

OCH2

CH2

Me2N

HOO O

OO OH O

OH

OCOCH3C CH3

CH2

CH3C COOCH3

CH2

CH3C

HOm m m

H2CC CH3C

O

OCH2

H2CMe2N

n

H2CC CH3C

O

OCH2CH2NMe2

n

CH2

C CH3CO

OCH2

H2CNMe2

n

CO

O

CH2

H2CNMe2

CO

OCH2

CH2

Me2N

OOOO

OO

OOO

Cl

OO

O

Cl

On n

OOOO

OO

OO

O OO

OOOOO

OO

OO

OO O

OOO

n n

nn

PCL backbone

PCLbackbone

70 OC

Agr-g-PMMA-b-PDMA

Amphiphilic gel of graft copolymer of Agr and PCL or PCMSt

Amphiphilic gel of Agr-g-PMMA-b-PDMA and PCL-Cl

Synthesis of Amphiphilic gel

Amphiphilic gel of Agr-g-PMMA-b-PDMA and PCMSt

Scheme 2.

Page 6: sustained release

Injectibility of APG particles

Agr-NMe2

+Cl-PCL-b-PEG-b-PCL-Cl

YY

Gel particles of size ~160 m was obtained by mechanical milling of liquid nitrogen frozen APG films and filtering the particles through 160 mesh sieves. The particles remain dispersed in water for about 10 min and are injectable through hypodermic syringe of needle size 20-G.

Mechanical milling

APGMembrane

Scheme 1. Injectibility of APG particles

Page 7: sustained release

Characterizations of precursors

Copolymer Agr/PMMA/PDMAz

(wt %)

PDI 

APCN gel

PDMA14.5-b-PMMA11-b-PDMA14.5-1

0/31/69 1.3 xAPCNtriblock-1a

PDMA14.5-b-PMMA11-b-PDMA14.5-1

0/31/69 1.81 yAPCNtriblock-1b

Agr115-g-PMMA47-b-PDMA56.2-1

60/20/20

1.73 xAPCNgraft-1

Agr115-g-PMMA40.4-co-PDMA58.8-2

32/68 1.62 xAPCNgraft-2

Agr115-g-PMMA31.2-b-PDMA54.5-3

59/15/26

1.68 xAPCNgraft-3a

Agr115-g-PMMA31.2-b-PDMA54.5-3

59/15/26

1.7 yAPCNgraft-3b

Table 1. x-PCMSt and y-ClCH2Ph-PCL-PhCH2Cl; APCN gels synthesized by reacting copolymers and PCMSt (copolymer:PCMSt=95:5, w/w) or ClCH2Ph-PCL-PhCH2Cl (copolymer:ClCH2Ph-PCL-PhCH2Cl=68:32, w/w); z-gravimetric analysis; subscript indicates Mnx10-3

of total grafting chains of PMMA or PDMA determined from 1H NMR while the Mn of Agr was obtained from GPC and viscosity measurements.

Fig.1: GPC traces of (a) Agr-I and (b) Agr-g-PMMA-b-PDMA-3. GPC was carried out by using DMF as eluent at  flow rate 0.8 mL/min

MV

-100.00

0.00

100.00

200.00

300.00

400.00

500.00

600.00

700.00

800.00

900.00

1000.00

1100.00

Minutes0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00

Fig 3: GPC trace of

Fig 2: GPC trace of PMMA and PDMA-b-PMMA

Page 8: sustained release

APCN APG Composition(wt %)

E (%) Swelling (%)

Water(Sw)

Toluene(St)

Agr PDMA PMMA PCMSt/PCL

APCNtriblock-1a 0 65 29 6/0 7.1 (±1) 61 (±3) 58 (±3)

APCNtriblock-1b 0 45 20 0/35 9.7 (±2) 19 (±3) 185 (±6)

APCNgraft-1 56 19 19 6/0 6.4 (±1) 49 (±2) 34 (±4)

APCNgraft-2 30 37 27 6/0 7.3 (±2) 42 (±1) 46 (±3)

APCNgraft-3a 56 25 13 6/0 7.2 (±2) 128 (±2) 35 (±3)

APCNgraft-3b 38 17 10 0/35 8.5 (±1) 102 (±3) 112 (±4)

Characterizations of APG membranes

Composition, extractable (E) and equilibrium swelling of APG membranes

Table 2: Composition, extractable (E) and equilibrium swelling of APG membranes

Page 9: sustained release

FD

ECA

B

G

H

I K

J L

Fig. 4:  Digital pictures of (A) dry, (B) water wet, (C) dry RB adsorbed, (D) water wet RB adsorbed, (E) dry riboflavin adsorbed and (F) water wet riboflavin adsorbed APCNgraft-3a showing transparency. 

Nanophase separated co-continuous structure

200 nm

D

200 nm

C

A

200 nm 200 nm

B

Fig.5:Phase mode AFM images of representative APCN gels. Images A-D are for APCNtriblock-1a, APCNtriblock-1b, APCNgraft-3a, and 

APCNgraft-3b respectively. The thin film was deposited on mica surface for AFM analysis. 

Page 10: sustained release

20 30 40 50 60 70 80 90 100 110 120 130

c'

c

b

a'

aHea

t flo

w (e

ndo)

Temparature (oC)

GraftPCL TriblockPCL tria graft1 graft3a

Fig. 6. DSC thermograms: (a) APCNtriblock-1a, (a') APCNtriblock-1b (b) APCNgraft-1, (c) APCNgraft-3a and (c') APCNgraft-3b. Tgs of PMMA (Tg= ca. 100 oC) and PDMA (Tg= ca. 35 oC).38 On the other hand, APCNgraft-3b and APCNtriblock-1b show single Tg at ca. 68 oC due to mixed PDMA/PMMA part. This indicates relatively high degree of phase miscibility in PCL containing APCNs.

Thermal phase analysis of APG membranes

DSC thermograms: (a) APCNtriblock-1a, (a') APCNtriblock-1b (b) APCNgraft-1, (c) APCNgraft-3a and  (c') APCNgraft-3b.

Tgs of PMMA (Tg= ca. 100 oC) and PDMA (Tg= ca. 35 oC).38 On the other hand, APCNgraft-3b and APCNtriblock-1b show single Tg at ca. 68 oC due to mixed PDMA/PMMA part. This indicates relatively high degree of phase miscibility in the PCL containing APCNs.

Page 11: sustained release

Tensile stress-strain property of APCN membranes

0 10 20 30 40 50 60 70 80 900

1

2

3

4

5

6

7

c'

ca

a'

co15 co41 triblock PCLgraftco Grfattri

b

Tens

ile st

ress (M

Pa)

Strain (%)

Fig. 7. Stress-strain profiles of (a) APCNtriblock-1a, (a') APCNtriblock-1b (b)

APCNgraft1, (c) APCNgraft-3a and (c') APCNgraft-3b. Stress-strain measurements (up to failure) were performed with the water swelled films.

The tensile stress-strain behavior of APCNs was significantly influenced by their degree of water swelling

The tensile stress (at break) follows the order for the APCNs, APCNtriblock-1b> APCNgraft-1>APCNtriblock-1a> APCNgraft3b~APCNgraft3a.

This order of tensile stress is due to enhanced swelling of the network in opposite order.

Page 12: sustained release

Degradation of APCN gel membranes

0 10 20 3070

75

80

85

90

95

100

Rem

aini

ng w

eigh

t (%

)

Hydrolytic time (day)

APCNgraft-3a at pH=5 APCNgraft-3b at pH=7.4 APCNgraft-3b at pH=5 APCNgraft-3b at pH=7.5

Characterizations of species formed by degradation of APGs

Fig. 8. Degradation profiles of representative APCNgraft-

3a and APCNgraft-3b at pHs 5 and 7.4.

APCNgraft-3a and APCNgraft-3b

undergo ca. 24% and 21% (w/w) degradations respectively at pH 5 for up to 30 days at 37 oC. The degradation was ca. 12% (w/w) for both the APCNs at pH 7.4

At acidic pH enhanced rate of degradation of Agr backbone of APCN due to hydrolytic cleavage of ester-linkages of reacted DMA moieties

The degraded species were soluble in water and formed foam in the degraded medium owing to their surface active nature

forms micelles with broad particle size distributions having hydrodynamic diameter ~135 nm and 142 nm respectively as confirmed by DLS analyses

pH 7.4 pH 5Fig. 9. foam formation APG membrane degraded species at pH 7.4 and pH 5

Page 13: sustained release

Drug Release from the APG membranes

0 20 40 60 80 100 120 140 160 1800

20

40

60

80

Cum

ulat

ive

rele

ase

(%)

Time (h)

pH=5pH=7.4

0 100 200 300 4000

10

20

30

40

50

60

Cum

ulat

ive

rele

ase

(%)

Time (h)

pH 5 pH 7.4 5-fluorouracil

APCNgraft 3a

5-fluorouracilAPCNgraft-3a

0 50 100 150 200 250 300 350 400

20

40

60

Time (h)

Cum

ulat

ive

rele

ase

(%)

A

pH 5 pH 7.4

0 50 100 150 200 250 300 350 4001.5

2.0

2.5

3.0

3.5

4.0

4.5

5.0

5.5

B

Dru

g re

leas

e (m

g)

Time (h)

pH 5 pH 7.4

Fig. 10. Release of prednisolone acetate at the outside the dialysis tubes from (A) APCNgraft-3a and (B) APCNgraft-3b at pH 5 and 7.4.

Prednisolone acetate APCNgraft-3a

Prednisolone acetate APCNgraft-3b

Fig. 11. Release of 5 Fluorouracil at the outside the dialysis tubes from (A) APCNgraft-3a and (B) APCNgraft-3b at pH 5 and 7.4..

(A)  (B) 

Page 14: sustained release

0.0

0.2

0.4

0.6

0.8

1.0

1.2

1.4 A

Con

trol

Deg

rade

d sp

ecies o

f APC

Ngr

aft-3a

APC

Ntrib

lock

-1b

APC

Ntrib

lock

-1a

APC

Ngr

aft-3

b

APC

Ngr

aft-3a

Sample

Cell v

iabi

lity

B E H K N Q

0

1

2

3

4

5

6

7 B

Sample

Hem

olys

is (%

)

Deg

rade

d sp

ecies o

f APC

Ngr

aft-3

a

APC

Ngr

aft-3

b

APC

Ngr

aft-3

a

APC

Ntr

iblo

ck-1

b

APC

Ntr

iblo

ck-1

a

B E

Cytocompatibility and blood compatibility assay

Fig. 12. Viability of HeLa cells after 24 h of incubation with APCN gels and species formed by degradation of representative APCNgraft-3a at 37 0C

Fig. 13. Hemocompatibility of APCN gels and degraded species of APCNgraft-3a after incubation with blood cells for 1 h at 37 0C

The cytocompatibility of APCN gels and species formed by degradation of representative APCN gels was determined by MTT assay using the HeLa cell line

The MTT assay indicates a high degree of cell viability after treating HeLa cells with various APCN gels. And degraded species of APCN with the polystyrene tissue culture plate (standard) indicates the cytocompatibility.

Hemocompatibility is also an essential criterion of materials for the Biomedical use

Hemolysis of RBCs in presence of various APCN and its degraded species in the presence of triton-X and 0.9% NaCl solution as positive and negative control .

Low hemolysis (5-6%) recorded. Its indicates high degree of hemocompatibility of APCN and its degraded species.

Page 15: sustained release

Synthesis of APGs from agarose amine and halide terminated polycaprolactone

O OO

O OHOO

OH

OHHO

Agr

O OO

O OHOO

OH

OHO

(A)

O

NNCH3NN

HCH3

HN

O

NCH3

CH3

H3C N NH2

CH3N N

NN

O

THF/16hroom temperature

DMPUNMP/120h

80 oC

CDIDMPA

Agr-NMe2

O

OH2C

H2C OHOH

OHO

OO

nO

OHO

O

n

O

O m

ClO

Cl

OO OO

OnO

OO

n

O

O mO O

Cl Cl

m

(B)

Et3N/24hroom temperature

1400C 6h

ClCH2Ph-PCL-b-PEG-b-PCL-PhCH2Cl

Sn(II)(Oct)2

O OO

O OHOO

OH

OHO

HN

O

N

CH3

CH3

OO OO

OnO

OO

n

O

O mO O

Cl Cl

(C)

70 OC

OO

N

OO

OnO

OO

n

O

O mO O

O OO

O OHOO

OH

OHO

O

N

CH3

CH3

N

OOO

OHO

OO

HO

OOH

O

N

CH3

H3C

(D)

Synthesis of precursors

Synthesis of Amphiphilic gel

Scheme 4. Synthesis of APGs from agarose amine and halide terminated polycaprolactone

O OOO

OnO

O OO

OmOO

OOO

OHOO

OHO

OOH

ONCH3

H3C

O OO

O OHO

OOH

OHO

O NCH3

CH3

D

Page 16: sustained release

Synthesis of APGs from agarose amine and halide terminated polycaprolactone

O OO

O OHOO

OH

OHHO

Agr

O OO

O OHOO

OH

OHO

(A)

O

NNCH3NN

HCH3

HN

O

NCH3

CH3

H3C N NH2

CH3N N

NN

O

THF/16hroom temperature

DMPUNMP/120h

80 oC

CDIDMPA

Agr-NMe2

O

OH2C

H2C OHOH

OHO

OO

nO

OHO

O

n

O

O m

ClO

Cl

OO OO

OnO

OO

n

O

O mO O

Cl Cl

m

(B)

Et3N/24hroom temperature

1400C 6h

ClCH2Ph-PCL-b-PEG-b-PCL-PhCH2Cl

Sn(II)(Oct)2

O OO

O OHOO

OH

OHO

HN

O

N

CH3

CH3

OO OO

OnO

OO

n

O

O mO O

Cl Cl

(C)

70 OC

OO

N

OO

OnO

OO

n

O

O mO O

O OO

O OHOO

OH

OHO

O

N

CH3

CH3

N

OOO

OHO

OO

HO

OOH

O

N

CH3

H3C

(D)

Synthesis of precursors

Synthesis of Amphiphilic gel

Scheme 4. Synthesis of APGs from agarose amine and halide terminated polycaprolactone

O OOO

OnO

O OO

OmOO

OOO

OHOO

OHO

OOH

ONCH3

H3C

O OO

O OHO

OOH

OHO

O NCH3

CH3

D

Page 17: sustained release

Characterization of precursors

ab

Fig. 14. GPC traces of (a) starting OH-PEG-OH (Mn=4000 g/mol) and (b) synthesized PCL-b-PEG-b-PCL. GPC was performed using THF as eluent (1 mL/min flow rate). The Mn(GPC) of PCL-b-PEG-b-PCL is 8100 and PDI is 1.28.

1800 1600 1400 1200 1000 800 600

Agr

Wavenumber (cm-1)

1715 cm-1Agr-NMe2

Fig. 15. IR spectra of Agr and Agr-NMe2. The spectrum of Agr-NMe2 showing extra band  at  1715  cm-1  due  to  presence  of carbonyl  (-C=O)  stretching  vibration  of  –O-CO-NH- group.

8 7 6 5 4 3 2 1 0

(ppm)

db e

DMSO-d6

ca

b

Fig. 16. 1H NMR (200 MHz) spectrum of Agr-NMe2 taken in DMSO-d6. The degree of amine substitution in Agr-NMe2 was calculated to be 0.31x.x-The degree of amine substitution in Agr-NMe2 was obtained by calculating molar ratio of -NMe2 to Agr from 1H NMR of Agr-NMe2 as follows: Degree of amine substitution = Ic/2Ia, where Ic is an integral area of the methylene proton (-CH2-CH2-NMe2, 2H, ô=1.87 ppm) of attached amine and Ia is an integral area of the O−CH−O proton (1H, ô=5.2 ppm from glucose units of Agr).

Page 18: sustained release

APG Agr/PCL or Agr/PCL-PEG-PCLa

(%, w/w)

Actual amount in APGc

(%, w/w)

Reaction mixture

Actual compositionb

Agr PCL PEG

Agr-PEG-PCL(1:1)

1:1 1:0.55 65 23 12

Agr-PEG-PCL(5:2)

1:0.4 1:0.21 83 11 6

Agr-PCL(1:1) 1:1 1:0.35 74 26 0

Agr-PCL(5:2) 1:0.4 1:0.15 86 14 0

Characterization of amphiphilic gel

Table 3. A-functional polymers and copolymers; b-calculated from two step (acetone and DMF) extraction process and c-from two step extraction and composition of PCL-b-PEG-b-PCL copolymer

Page 19: sustained release

DMF Sol fraction and equilibrium swelling of different APG membranes

Conetwork Sol fraction (%)

Swelling (%)

Water Toluene

Agr-PEG-PCL(1:1) 28 (±2) 178 (±6) 22 (±1)

Agr-PEG-PCL(5:2) 18 (±2) 192 (±7) 15 (±2)

Agr-PCL(1:1) 40 (±3) 154 (±5) 36 (±1)

Agr-PCL(5:2) 23 (±3) 163 (±4) 28 (±2)

Agr-PEG (1:1) 10 (±2) 240 (±4) -

Table 4. DMF Sol fraction and equilibrium swelling of different APG membranes

Page 20: sustained release

A D

B E

G H

FCJ

I

Fig. 17. Digital pictures of APGs films showing comparative transparency. Pictures: A (dry), B (water swelled) and C (toluene swelled) Agr-PEG-PCL(1:1) films. Pictures D (dry), E (water swelled) and F (toluene swelled) Agr-PCL(1:1) films. Pictures G and H are for RB adsorbed Agr-PEG-PCL(1:1) and Agr-PCL(1:1)

Nanophase separated co-continuous structure

Fig. 18. Images I and J are for phase mode AFM images (5x5 µ) of Agr-PEG-PCL(1:1) and Agr-PCL(1:1) respectively. The thin film was deposited on mica surface for AFM analysis

Page 21: sustained release

Phase separation behavior by DSC analysis of APGs

-50 0 50 100 150

(e)

(d)

(c)

(b)

(a)

A

Hea

t flo

w (e

ndo)

40 0

C

82 0

C

74 0

C

Temperature (oC)

Agr-PCL(1:1) Agr-PEG-PCL(1:1) Agr Agr+PCL(1:1) PCL

-70 -68 -66 -64 -62 -60

d

b

a

-690C

B

 Fig. 19. Curves a-e are DSC thermograms of Agr-PCL(1:1), Agr-PEG-PCL(1:1), neat Agr, neat PCL and mechanical mixture of Agr+PCL (1:1, w/w) respectively, (B) extended scale DSC thermograms

Page 22: sustained release

-50 0 50 100 1500.08

0.10

0.12

0.14

0.16

0.18

0.20

0.22

0.24

Agr-PEG-PCL(1:1)

Agr-PEG-PCL(1:1)

B

55 oC

43 oC

Tan

delta

(MPa

)

Temperature (oC)

-50 0 50 100 1500

200400600800

100012001400160018002000220024002600

A-70 oC

-62 oC

65 oC

Agr-PEG-PCL(1:1)

Agr-PCL(1:1)

Stor

age

mod

ulus

(MPa

)

Temperature (o C)

Fig. 20. Storage modulus and tan delta vs. temperature plots of representative Agr- Agr-PCL(1:1) and PEG-PCL(1:1) showing glass transition regions and temperature dependent mechanical property

Thermal phase analysis of APGs

Page 23: sustained release

0 20 40 60 80 1000.0

0.2

0.4

0.6

0.8

1.0(a) Agr-PCL (5:2)(b) Agr-PCL (1:1)(c) Agr-PEG-PCL (5:2)(d) Agr-PEG-PCL (1:1)

(a)

(b)

(c)

(d)

Stre

ss (M

Pa)

Strain (%)

Tensile Stress-Strain Property of APG membranes

Fig. 21. Tensile stress-strain properties of APGs in their equilibrium water swelled state.

Higher amount of PCL in the APGs also enhances the stress-strain property of Agr-PEG-PCL(1:1) and Agr-PCL(1:1) by lowering the water swelling compared to corresponding Agr-PEG-PCL(5:2) and Agr-PCL-(5:2) respectively

Phase separation probably helps to transfer of applied stress from water swelled Agr and PEG to semi-crystalline PCL

Page 24: sustained release

0 10 20 30 40 50 600

5

10

15

20

25

30 Agr-PCL(1:1), pH=7.4 Agr-PEG-PCL(1:1), pH=7.4 Agr-PCL (1:1), Lipase, pH=7.4 Agr-PEG-PCL (1:1), Lipase, pH=7.4 Agr-PCL (1:1), pH=5 Agr-PEG-PCL (1:1), pH=5

Deg

rada

tion

(%, w

/w)

Time (Day)

Degradation of APGs

Fig. 22. Degradation of Agr-PCL(1:1) and Agr-PEG-PCL(1;1) in presence of 0.007 (M) aqueous NaOH of pH 9, lipase (0.1%, w/v), 7.4 PBS and PBS of pH 5 for up to 60 days at 37 oC.

Catalyzed degradation of representative Agr-PEG-PCL(1:1) and Agr-PCL-(1:1). The rate of degradation enhances in PEG containing APG in both the catalysed process.

The enhanced rate of degradation of PEG containing APGs is attributed to the enhanced water swelling of the APGs which facilitate the diffusion of OH- or lipase to the proper chemical site and thereby catalysed the degradation compared to only PCL containing APGs.

The rate of degradation enhances in presence of lipase than that of NaOH due to more hydrolytic instability of ester bond of PCL in presence of lipase.

Page 25: sustained release

a

a'

b

b' c'

c d

d'

0 10 20 30 40 500

5

10

15

20

25

30

35

40 A

Load

ing

capa

sity

(%)

Time (h)

Agr-PEG-PCL(1:1) Agr-PCL(1:1) Agr-PEG-PCL(5:2) Agr-PCL(5:2)

Hydrophilic drug loading APG membrane

5-Fluorouracil

Fig. 23. Digital pictures of unloaded (pictures a, b, c and d) and 5-fluorouracil loaded (a', b', c 'and d') Agr-PCL(5:2), Agr-PEG-PCL(5:2), Agr-PCL(1:1) and Agr-PEG-PCL(1:1) respectively showing relative transparency

Fig. 24. 5-fluorouracil loading capacity of APGs with drug concentration

a b

0 10 20 30 40 500

5

10

15

20

25

30

Load

ing

Cap

asity

( %

, w/w

)

Time (h)

Agr-PEG-PCL(1:1) Agr-PCL(1:1)

Fig. 26. Gemcitabine loading capacity of APGs with drug concentration 

Fig. 25. Digital pictures (a and b) of gemcitabine hydrochloride loaded Agr-PCL(1:1) and Agr-PEG-PCL(1:1) respectively

Page 26: sustained release

Hydrophobic drug (Prednisolone acetate ) loading capacity

0 10 20 30 40 5005

10152025303540 A

Load

ing

capa

sity

(%)

Time (h)

Agr-PEG-PCL (1:1) Agr-PCL (1:1) Agr-PEG-PCL (5:2) Agr-PCL (5:2)

Prednisolone acetate

Fig. 27. 5-fluorouracil loading capacity of APGs with drug concentration

b

a

The loading of hydrophobic prednisolone acetate is governed by the amount of hydrophobic component and extent of water swelling of APGs.

The prednosolone acetate loading capaity of Agr-PCL(5:2) and Agr-PCL(1:1) is higher than that of corresponding PEG containing APGs due to high degree of solubilization of the drug by PCL rich phase

This is because the amount of PCL in Agr-PCL(5:2) and Agr-PCL(1:1) is higher than that of corresponding PEG containing APGs.

Fig. 28. digital pictures of prednisolone acetate loaded (a) Agr-PCL(1:1) and (B) Agr-PEG-PCL(1:1).

Page 27: sustained release

Stability of drugs ( Prednisolone acetate and 5-Fluorouracil) in the APG membrane matrices

The 5-Flu and prednisolone acetate remained stable inside the APGs as confirmed by

UV-Visible and IR analyses.

The drugs loaded films were stored in air at room temperature for six months and

then the released experiments were conducted for UV-visible analysis.

The absorbance maximum of released 5-Fluo (λmax= 266 nm) and prednisolone acetate

(λmax= 247 nm) remained same as that of pure drugs.

The IR spectra of loaded drugs taken after six months of loading, also exhibited

similar spectra

Fig. 29.

Page 28: sustained release

0 50 100 150 200 250 300 3500

5

10

15

20

25

30

35B

Cum

mul

ativ

e re

leas

e (%

)

Time (h)

Agr-PCL(5:2), pH 7.4 Agr-PEG-PCL(5:2), pH 7.4

0 50 100 150 200 250 300 3500

10

20

30

4050

60

70 C

Cum

mul

ativ

e re

leas

e (%

, w/w

)

Time (h)

Agr-PCL(1:1) Film, pH 7.4 Agr-PCL(1:1) Powder, PH 7.4 Agr-PCL(1:1), pH 5 Agr-PCL(1:1), Lipase, pH 7.4 Agr-PEG-PCL(1:1) Film, pH 7.4 Agr-PEG-PCL(1:1) Powder, pH 7.4 Agr-PEG-PCL(1:1), pH 5 Agr-PEG-PCL(1:1), Lipase pH 7.4

Controlled release of hydrophilic drugs (5-Fu)

Fig. 30. The cumulative release of 5-fluorouracil with time from Agr-PCL(1:1) and Agr PCL(5:2) and Agr-PEG-PCL(1:1), Agr-PEG-PCL(5:2) in 7.4 pH, 5pH and presence of Lipase enzyme Agr-PEG-PCL(1:1 ) releases 5-Fu is very slow in comparison to Agr-PCL(1:1)

due to the solubilizing effect of PEG PEG enhanced the phase mixing and internal solubilizing of hydrophilic

drug which also restrict the its release in the medium Release of 5-Fu in liase is higher due to degradation of ester linkage of PEG-

PCL

Page 29: sustained release

Interaction of PEG with 5-fluorouracil

Fig. 31. UV-Visible spectra of 5-fluorouracil in water and in water containing PEG

respectively. Concentration of 5-fluorouracil

200 250 300 3500.0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

max

5-fluorouracil+water

5-fluorouracil+water+PEG solution

Abso

rban

ce

Wavelength (nm)0 2 4 6 8 10

0

20

40

60

80

100

Cum

mul

ativ

e R

elea

se (%

)

Time (h)

Drug in water Drug in PEG solution

100 150 200 250 300-0.7-0.6-0.5-0.4-0.3-0.2-0.10.00.10.20.30.40.50.60.7

Cp= 3.20 J/(g*K)

Cp= 4.247 J/(g*K)

Agr-PEG-PCL(1:1)/5-Flu

Agr-PCL(1:1)/5-Flu

Heat

flow

(mW

/mg)

Temperature (o C)

5-fluorouracil solubilizing effect of PEG

Fig. 32. 5-FU release from water and PEG solution

Fig. 33. DSC of APG with 5-FUFig. 34. Relative transparency of APG membrane in presence of 5-FU

Page 30: sustained release

Controlled release of hydrophilic drugs gemcitabine

0 50 100 150 200 250 300

3

6

9

12

15

B

Cum

mul

ativ

e re

leas

e (%

)

Time (h)

Agr-PEG-PCL (5:2) Agr-PCL (5:2)

a b

Fig. 35. Cumulative release of gemcitabine hydrochloride with time (B) from representative Agr-PEG-PCL(1:1) and Agr-PCL(1:1).

Fig. 36. Digital pictures (a and b) of gemcitabine hydrochloride loaded Agr-PCL(1:1) and Agr-PEG-PCL(1:1)respectively

Release rate of gemcitabine is relatively higher from Agr-PEG-PCL(5:2) than Agr-PCL(5:2) due to hydrophilic nature of gemcitabine and Agr-PEG-PCL(5:2) have higher degree of swelling than Agr-PCL(5:2)

Page 31: sustained release

0 50 100 150 200 250 300 3500

10

20

30

40

50

60

70C

Cum

mul

ativ

e re

leas

e (%

)

Time (h)

Agr-PCL(1:1), pH 7.4 Agr-PCL(1:1), pH 5 Agr-PCL(1:1), Lipase, pH7.4 Agr-PEG-PCL(1:1), pH 7.4 Agr-PEG-PCL(1:1), pH 5 Agr-PEG-PCL(1:1), Lipase, pH 7.4

0 50 100 150 200 250 3000

5

10

15

20

25

30

35B

Cum

mul

ativ

e re

leas

e (%

)

Time (h)

Agr-PCL(5:2), pH 7.4 Agr-PEG-PCL(5:2), pH 7.4

Controlled release of hydrophobic drug (prednisolone acetate)

Fig. 37. Cumulative release of prednisolone acetate with time from different APGs in PBS of pH 7.4 and in PBS of pH 7.4, 5 and lipase (pH=7.4) respectively

The release rate of prednisolone acetate is less in Agr-PCL(1:1) andAgr-PCL(5:2) than Agr-PEG-PCL(1:1), Agr-PEG-PCL(5:2) due to high degree of solubilization of the drug by PCL rich phase

This is because the amount (14% and 26%) of PCL in Agr-PCL(5:2) and Agr-

PCL(1:1) is higher than that of (11% and 23%) Agr-PEG-PCL(5:2) and Agr-PEG-PCL(1:1)

Page 32: sustained release

Drug release kinetics

After the initial burst release from all three types of drugs, the regression coefficient values (R2) obtained from the zero order kinetic model were greater than those from the first order kinetic model

The diffusion exponent (n) values obtained from the Korsmeyer−Peppas Model are between 0.63-0.64 which indicates that non-Fickian diffusion mechanism; i.e., combination of diffusion and erosion of the matrix predominate. The R2 values obtained with Hixson−Crowell Modelare greater than that of Higuchi model.

Korsemeyer, R. W.; Gurny, R.; Doelker, E.; Buri, P.; Peppas, N. A. Int. J. Pharm. 1983, 15, 25−35.Hixson, A. W.; Crowell, J. W. Ind. Eng. Chem. 1931, 23, 923−931.Higuchi, T. J. Pharm. Sci. 1961, 50, 874−875. 

Page 33: sustained release

Cytocompatibility and blood compatibility assay

Fig. 38. Viability of HeLa cells after 24 h of incubation with APCN gels and species formed by degradation of representative APCNgraft-3a at 37 0C

Fig. 39. Hemocompatibility of APCN gels and degraded species of APCNgraft-3a after incubation with blood cells for 1 h at 37 0C

The cytocompatibility of APCN gels and species formed by degradation of representative APCN gels was determined by MTT assay using the HeLa cell line

The MTT assay indicates a high degree of cell viability after treating HeLa cells with various APCN gels. And degraded species of APCN with the polystyrene tissue culture plate (standard) indicates the cytocompatibility.

Hemocompatibility is also an essential criterion of materials for the Biomedical use

Hemolysis of RBCs in presence of various APCN and its degraded species in the presence of triton-X and 0.9% NaCl solution as positive and negative control .

Low hemolysis (5-6%) recorded. Its indicates high degree of hemocompatibility of APCN and its degraded species.

0

20

40

60

80

100

120

140

160

ACe

llviability (%

)

Agr-PE

G-PCL

(1:1)

Agr-P

EG-PCL(5:2)

Agr-P

CL(1:1)

Agr-PC

L(5:2)

Con

trol

APG

B E

0

1

2

3

4

5

6

7 B

Agr

-PEG

-PC

L(1:

1)

Agr

-PEG

-PC

L(5:

2)

Agr

-PC

L(1:

1)

Agr-

PCL(

5:2)

Hem

olys

is (%

)

APG

Page 34: sustained release

Future work plan

1. Synthesis of purely Agr and PCL-based porous APG membranes for tissue culture application.

2. Dextran-based antimicrobial and biocompatible polymers and gel

Page 35: sustained release

Publications 

 Effect of Polyethylene glycol on Properties and Drug Encapsulation-Release Performance of Biodegradable/Cytocompatible Agarose-Polyethylene glycol-Polycaprolactone Amphiphilic Gels Arvind k. Singh Chandel, Chinta Uday Kumar and bSuresh K. Jewrajka* 

Communicated for publication

Page 36: sustained release

Thank You….